0000849146-18-000032.txt : 20180206 0000849146-18-000032.hdr.sgml : 20180206 20180206163734 ACCESSION NUMBER: 0000849146-18-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180202 FILED AS OF DATE: 20180206 DATE AS OF CHANGE: 20180206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McMurray Kevin CENTRAL INDEX KEY: 0001718176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35647 FILM NUMBER: 18578084 MAIL ADDRESS: STREET 1: 9785 S. MONROE STREET, SUITE 300 CITY: SANDY STATE: UT ZIP: 84070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9785 S. MONROE STREET STREET 2: SUITE 300 CITY: SANDY STATE: UT ZIP: 84070 BUSINESS PHONE: 801-432-9000 MAIL ADDRESS: STREET 1: 9785 S. MONROE STREET STREET 2: SUITE 300 CITY: SANDY STATE: UT ZIP: 84070 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 4 1 wf-form4_151795303653325.xml FORM 4 X0306 4 2018-02-02 0 0000849146 Lifevantage Corp LFVN 0001718176 McMurray Kevin 9785 S. MONROE STREET, SUITE 300 SANDY UT 84070 0 1 0 0 General Counsel Stock Option (Right to Buy) 4.44 2018-02-02 4 A 0 39500 0 A 2028-02-01 Common Stock 39500.0 39500 D Phantom Shares 2018-02-02 4 A 0 19750 0 A Common Stock 19750.0 19750 D This stock option will vest as follows: (i) 1/3 of the option vests on January 1, 2019 and (ii) an additional 1/12 of the option vests each quarter for each of the 24 months following January 1, 2019, subject to continued service with the company. Each Phantom Share represents the right to be paid in cash an amount equal to any increase in value of a single share of LFVN common stock, measured from December 31, 2017 to December 31, 2018. Phantom Shares will be settled following certification of achievement of the price-based condition, which will occur no later than March 15, 2019. /s/ Kevin McMurray 2018-02-06